Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cumulative Live Birth Rates in Dual Ovarian Stimulation Versus Two Antagonist Stimulations in Poor Ovarian Responders
Sponsor: Shanghai First Maternity and Infant Hospital
Summary
To compare the difference in cumulative live birth rates between dual ovarian stimulation and two antagonist stimulations in poor ovarian responders.
Official title: A Randomized Clinical Trial Comparing Cumulative Live Birth Rates in Dual Ovarian Stimulation Versus Two Antagonist Stimulations in Poor Ovarian Responders
Key Details
Gender
FEMALE
Age Range
20 Years - 44 Years
Study Type
INTERVENTIONAL
Enrollment
260
Start Date
2023-11-01
Completion Date
2026-10-30
Last Updated
2023-10-23
Healthy Volunteers
No
Conditions
Interventions
duostim vs. two antagonist ovarian stimulations
Human menopausal gonadotropin (HMG) 300 IU/day with flexible antagonist protocol is used for ovarian stimulation, except in luteal phase stimulation of the duostim group. In the duostim group, all of the embryos are frozen. Fresh transfers are performed in the control group, frozen embryo transfers are performed in both control and duostim groups.